Cargando…
A Step-up Approach for Cell Therapy in Stroke: Translational Hurdles of Bone Marrow-Derived Stem Cells
Stroke remains a significant unmet condition in the USA and throughout the world. To date, only approximately 3% of the population suffering an ischemic stroke benefit from the thrombolytic drug tissue plasminogen activator, largely due to the drug’s narrow therapeutic window. The last decade has wi...
Autores principales: | Glover, Loren E., Tajiri, Naoki, Weinbren, Nathan L., Ishikawa, Hiroto, Shinozuka, Kazutaka, Kaneko, Yuji, Watterson, D. Martin, Borlongan, Cesar V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284662/ https://www.ncbi.nlm.nih.gov/pubmed/22389662 http://dx.doi.org/10.1007/s12975-011-0127-8 |
Ejemplares similares
-
Stem Cell Transplantation for Neuroprotection in Stroke
por: Shinozuka, Kazutaka, et al.
Publicado: (2013) -
Addendum: Shinozuka, K. et al. Stem Cell Transplantation for Neuroprotection in Stroke. Brain Sci. 2013, 3, 239–261
por: Shinozuka, Kazutaka, et al.
Publicado: (2017) -
Toward Personalized Cell Therapies: Autologous Menstrual Blood Cells for Stroke
por: Rodrigues, Maria Carolina O., et al.
Publicado: (2011) -
Stem Cell Recruitment of Newly Formed Host Cells via a Successful Seduction? Filling the Gap between Neurogenic Niche and Injured Brain Site
por: Tajiri, Naoki, et al.
Publicado: (2013) -
Combination Therapy of Human Umbilical Cord Blood Cells and Granulocyte Colony Stimulating Factor Reduces Histopathological and Motor Impairments in an Experimental Model of Chronic Traumatic Brain Injury
por: Acosta, Sandra A., et al.
Publicado: (2014)